Skip to content

Study · Not a test of the peptide alone · 1995

2 results

[Immunological and nonspecific reactivity in patients with infiltrative pulmonary tuberculosis associated with chronic nonspecific lung diseases].

Morozova TI, Khudzik LB, Rebrov AP

Problemy tuberkuleza1 Jan 1995

PMID7567859 (opens in a new tab)PepBankPUB-07567859
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In pulmonary tuberculosis patients, aerosol protease inhibitors and thymalin increased etiotropic treatment efficacy.

    In plain wordsIn tuberculosis patients, aerosol protease inhibitors and thymalin increased treatment efficacy.

    Peptide
    Thymalin
    Outcome
    IncreaseEtiotropic treatment efficacy
    Study

    n: not reported in source

    Outcome group
    Infection and antimicrobial activity · Respiratory

    Source sentences

    Summary
    Nonspecific aerosol treatment with native protease inhibitors (contrykal or gordox) and thymalin aroused the efficacy of etiotropic treatment and promoted normalization of the above defense systems.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with pulmonary tuberculosis, aerosol protease inhibitors and thymalin promoted normalization of the disturbed defense systems (immunity, complement and protease inhibitors).

    In plain wordsIn tuberculosis patients, protease inhibitors and thymalin helped normalize the disturbed immune, complement and protease inhibitor systems.

    Peptide
    Thymalin
    Outcome
    Not applicableNormalization of defense systems
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Nonspecific aerosol treatment with native protease inhibitors (contrykal or gordox) and thymalin aroused the efficacy of etiotropic treatment and promoted normalization of the above defense systems.
    1 context sentence
    Summary · context
    exhibited disturbances in cellular and humoral immunity, complement activity, content of alpha 1 protease inhibitor and alpha 2 macroglobulin which aggravated in combined respiratory pathology.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.